医疗补助系统性红斑狼疮患者初始羟氯喹获得的预测因素
该研究基于2000-2010年Medicaid理赔数据,纳入9560例新发SLE患者,发现仅41%在诊断后24个月内首次获得HCQ/CQ。年轻患者及所有非白人种族/族裔获得率更高,而酒精/尼古丁使用、慢性疼痛、糖尿病和终末期肾病与较低获得率相关,门诊和预防保健服务与较高获得率相关。
要点
- 仅41%新发SLE患者在24个月内获得HCQ/CQ,获得率偏低。
- 非白人种族/族裔首次获得HCQ/CQ的比率均高于白人。
- 门诊和预防保健服务增加获得率,住院增多则降低获得率。
核心结论
- 仅41%的Medicaid新发SLE患者在诊断后24个月内首次获得HCQ/CQ。
- 所有非白人种族/族裔首次获得HCQ/CQ的比率均高于白人。
- 首次获得HCQ/CQ的时间可能无法解释不良结局中的种族/族裔差异。
研究设计与样本
- 使用2000至2010年Medicaid保险理赔数据,识别18-65岁新发SLE患者。
- 新发SLE定义为至少3个SLE的ICD-9编码且间隔至少30天,此前24个月无SLE编码或HCQ/CQ使用。
- 主要结局为首次SLE编码后24个月内首次获得HCQ/CQ。
- 采用Cox比例风险回归模型分析社会人口学因素、合并症、医疗利用和用药与HCQ/CQ发放的关联。
主要发现
- 共识别9560例Medicaid新发SLE受益人,其中41%在诊断后24个月内获得HCQ(n=3949)或CQ(n=14)。
- 年轻患者更可能获得HCQ/CQ。
- 黑人、亚裔、西班牙裔和美洲印第安人/阿拉斯加原住民个体比白人更可能获得HCQ/CQ。
- 酒精和尼古丁使用、慢性疼痛、糖尿病和终末期肾病与较低发放率相关。
- 门诊预约和预防保健服务与较高发放率相关,住院次数越多与较低发放率相关。
关键数值与推荐
- 新发SLE定义:≥3个SLE的ICD-9编码且间隔≥30天,此前24个月无SLE编码或HCQ/CQ使用。
- 主要结局:首次SLE编码后24个月内首次获得HCQ/CQ。
- 共9560例新发SLE患者,41%获得HCQ(n=3949)或CQ(n=14)。
临床怎么用
- 应关注Medicaid新发SLE患者中HCQ/CQ获得率较低的问题。
- 增加门诊和预防保健服务可能提高HCQ/CQ的获得率。
- 需考虑其他医疗质量相关问题及用药依从性挑战,而非仅关注初始获得时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although hydroxychloroquine/chloroquine (HCQ/CQ) form the cornerstone of systemic lupus erythematosus (SLE) treatment, not all patients receive this, which may contribute to disparities in outcomes. The present study was undertaken to investigate factors associated with first dispensing of HCQ/CQ. METHODS: Using Medicaid insurance claims from 2000 to 2010, we identified individuals ages 18-65 years with incident SLE (≥3 SLE International Classification of Diseases, Ninth Revision codes separated by ≥30 days without prior SLE codes or HCQ/CQ use for 24 months). The primary outcome was first dispensing of HCQ/CQ within 24 months of the first SLE code. We used Cox proportional hazards regression models to examine the association between sociodemographic factors, comorbidities, health care utilization, and medication use and HCQ/CQ dispensing within 24 months of diagnosis. RESULTS: We identified 9,560 Medicaid beneficiaries with incident SLE; 41% received HCQ (n = 3,949) or CQ (n = 14) within 24 months of diagnosis. Younger patients were more likely to receive HCQ/CQ. Black, Asian, Hispanic, and American Indian/Alaska Native individuals were more likely to receive HCQ/CQ than White individuals. Alcohol and nicotine use, chronic pain, diabetes mellitus, and end-stage renal disease were associated with lower dispensing. Appointments and preventive care services were associated with higher rates, and more hospitalizations with lower rates. CONCLUSION: Only 41% of Medicaid beneficiaries with SLE received HCQ/CQ within 24 months of diagnosis. Greater outpatient and preventive care increased receipt. All non-White race/ethnicities had higher rates of first dispensing. Time to initial HCQ/CQ dispensing may not explain racial/ethnic disparities in adverse outcomes, highlighting the need to consider other care quality-related issues and medication adherence challenges.
引用
- Pryor KP, Xu C, Collins JE, et al. Predictors of Initial Hydroxychloroquine Receipt Among Medicaid Beneficiaries With Incident Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2022. PMID: 33555101. doi:10.1002/acr.24572
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。